Trial intelligence / Profile preview

HSK21542 for Hemodialysis-Associated Pruritus (Phase II)

CTR20201702Phase 2Completed

Sponsor
Sichuan Haisco Pharmaceutical Co., Ltd.
Start
Aug 2020
Modality
Small Molecules, Peptides
Countries
1
01

Overview

A Phase 2 trial of hsk21542 in chronic kidney disease-associated pruritus (CKD-aP), sponsored by Sichuan Haisco Pharmaceutical Co., Ltd.. Started Aug 2020; status: completed.

02

Drugs

hsk21542
03

Conditions

chronic kidney disease-associated pruritus (CKD-aP)

Beyond the preview

Go deeper on CTR20201702.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20201702.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call